These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Paraoxonase 1 (PON1) is present in postprandial chylomicrons. Fuhrman B; Volkova N; Aviram M Atherosclerosis; 2005 May; 180(1):55-61. PubMed ID: 15823275 [TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease. Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192 [TBL] [Abstract][Full Text] [Related]
7. Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma. Kunes JP; Cordero-Koning KS; Lee LH; Lynch SM Nutr Res; 2009 Feb; 29(2):114-22. PubMed ID: 19285602 [TBL] [Abstract][Full Text] [Related]
8. Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis. Mahrooz A; Zargari M; Sedighi O; Shaygani H; Gohari G Clin Invest Med; 2012 Jun; 35(3):E144-51. PubMed ID: 22673317 [TBL] [Abstract][Full Text] [Related]
9. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo. Gugliucci A Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342 [TBL] [Abstract][Full Text] [Related]
10. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease. Göçmen AY; Gümüşlü S; Semiz E Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047 [TBL] [Abstract][Full Text] [Related]
11. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks. Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515 [TBL] [Abstract][Full Text] [Related]
12. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation. Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818 [TBL] [Abstract][Full Text] [Related]
13. Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies. Efrat M; Rosenblat M; Mahmood S; Vaya J; Aviram M Atherosclerosis; 2009 Feb; 202(2):461-9. PubMed ID: 18585720 [TBL] [Abstract][Full Text] [Related]
14. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. Rosenblat M; Karry R; Aviram M Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851 [TBL] [Abstract][Full Text] [Related]
15. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins. Hazell LJ; Davies MJ; Stocker R Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):489-95. PubMed ID: 10215584 [TBL] [Abstract][Full Text] [Related]
16. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action. Nguyen SD; Sok DE Free Radic Res; 2003 Dec; 37(12):1319-30. PubMed ID: 14753756 [TBL] [Abstract][Full Text] [Related]
17. Assessment of amino-terminal C-type natriuretic peptide serum level and its correlation with high-density lipoprotein structure and function in patients with end stage renal disease before and after kidney transplantation. Szentimrei R; Lőrincz H; Szentpéteri A; Varga VE; Seres I; Varga É; Nemes B; Harangi M; Paragh G Chem Biol Interact; 2023 Nov; 385():110749. PubMed ID: 37802408 [TBL] [Abstract][Full Text] [Related]
18. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus. Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558 [TBL] [Abstract][Full Text] [Related]
19. Renal cortical thickness and PON1 activity both decrease in chronic renal failure. Ak G; Ozgönül M; Sözmen EY; Aslan SL; Sözmen B J Nephrol; 2002; 15(2):144-9. PubMed ID: 12018630 [TBL] [Abstract][Full Text] [Related]